Search - tctmd.com

Displaying 81 - 100 of 2051

Sort: Relevancy | Date

Presentation TCT 2016

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Philippines Presents a Case: Cardiogenic Shock in Non-STEMI

Presenter: Rui Campante Teles, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 30, 2016

Presentation TCT 2016

TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

STEMI Treatment Strategies: Drugs and Devices

Presenter: Tayo A. Addo, Dharam J. Kumbhani

October 30, 2016

Presentation TCT 2016

NSTEACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Presenter: C. Michael Gibson, Daniel I. Simon, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Acute Coronary Syndromes: STEMI

Presenter: Peter Barlis, Grzegorz L. Kaluza, Michael C. Kim

October 29, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

ABSOLUTE FLOW: Concepts And Practical Aspects

Presenter: Nico H. J. Pijls

October 28, 2016

News Opinion Fellow Talk

Top 10 Tricks for Transradial Procedures

October 10, 2016

News Daily News

Cool It With the Therapeutic Hypothermia for In-Hospital Cardiac Arrest, Study Suggests

Yael L. Maxwell

October 10, 2016

News Daily News

STEMI 患者 CTO PCI 前沿：EXPLORE 带来更多问题

Yael L. Maxwell

October 05, 2016

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

Advertisement

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Philippines Presents a Case: Cardiogenic Shock in Non-STEMI

TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

STEMI Treatment Strategies: Drugs and Devices

NSTEACS: Risk Stratification and Treatment

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Acute Coronary Syndromes: STEMI

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

ABSOLUTE FLOW: Concepts And Practical Aspects

Top 10 Tricks for Transradial Procedures

Cool It With the Therapeutic Hypothermia for In-Hospital Cardiac Arrest, Study Suggests

STEMI 患者 CTO PCI 前沿：EXPLORE 带来更多问题

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content